Since the use of CBD officially became legal in the UK in 2017, followed by medicinal cannabis in 2018, demand has risen considerably.
Medicinal Cannabis
Analytical Testing
Customized Testing for Your Medicinal Cannabis Products
We partner with innovators in the medicinal cannabis market, combining fast testing turnaround with our expertise in compliance and quality control to help bring products to market. As a GMP-certified facility with a Controlled Drugs license, we are uniquely equipped to support safe, compliant product development from inception to market launch.
Analytical Method Development and Validation
Stability Storage and Analysis
Cannabinoid Sample Analysis and Characterization
Scientific Product Development
Regulatory Support and Consultation
Analytical Method Development and Validation
We develop and validate analytical methods tailored to your project’s specific needs.
Our process includes the seamless transfer of methods from in-house or external laboratories, helping to accelerate your project while reducing development time. We also address any technical issues with existing methods to ensure optimal performance.
Arrange a meeting with a scientific or regulatory expert to discuss your medicinal cannabis or CBD project and learn how we can help ensure your product's safety, efficacy, and quality.
Cannabis Testing Services Resources
Learn more about how we can help bring your medicinal cannabis or CBD product to market through our high-quality analytical testing services.
Broughton: Your Medical Cannabis Compliance and Market Entry Partner
As the medical cannabis market grows, expertise in testing, regulatory compliance, and quality control play a pivotal role in assisting category innovators in bringing their products to market.
A step by step guide to Cannabis Testing
This guide examines the key steps in the cannabis analytical testing process and what cultivators need to consider when selecting a testing partner.
Unlock the Potential of Your Medicinal Cannabis Products
As the beneficial effects of medicinal cannabis gain greater acceptance and more consumers begin to use cannabis-derived products, there is an ever-increasing need for cultivators to ensure that their products are tested to the required standards to ensure both product safety and quality.
Whitepaper: Does CBD Really Harm the Liver?
Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.
Whitepaper: A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market
Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route.
Whitepaper: Review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions
In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Whitepaper: The importance of the human endocannabinoid system when developing therapeutic cannabis products
To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.
Cannabis Services
Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services.
To streamline and speed up the UK supply chain of medicinal cannabis, Broughton has launched a set of methods for cannabis batch release testing.
I recently had the privilege of attending the Cannabis Europa conference in London on June 25-26, representing Broughton Life Sciences as a Business ....
Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.
